Ticinesi Andrea, Parise Alberto, Nouvenne Antonio, Cerundolo Nicoletta, Prati Beatrice, Guerra Angela, Tuttolomondo Domenico, Gaibazzi Nicola, Meschi Tiziana
Department of Medicine and Surgery, University of Parma, Parma, Italy.
Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Front Med (Lausanne). 2023 Feb 1;10:1112728. doi: 10.3389/fmed.2023.1112728. eCollection 2023.
The reasons of variability of clinical presentation of coronavirus disease-19 (COVID-19) across different pandemic waves are not fully understood, and may include individual risk profile, SARS-CoV-2 lineage and seasonal variations of viral spread. The objective of this retrospective study was to compare the characteristics and outcomes of patients admitted with confirmed coronavirus disease-19 (COVID-19) in the same season during the first (March 2020) and the third pandemic wave (March 2021, dominance of SARS-CoV-2 B.1.1.7 lineage) in an internal medicine ward of a large teaching hospital in Italy.
Data of 769 unvaccinated patients (399 from the first and 370 from the third wave) were collected from clinical records, including symptom type and duration, extension of lung abnormalities on chest computed tomography (CT) and PaO/FiO ratio on admission arterial blood gas analysis.
Third wave patients were in average younger (median 65, interquartile range [IQR] 55-75, vs. 72, IQR 61-81 years old, < 0.001), with less comorbidities and better pulmonary (CT visual score median 25, IQR 15-40, vs. 30, IQR 15-50, age- and sex-adjusted = 0.017) and respiratory involvement (PaO/FiO median 288, IQR 237-338, vs. 233, IQR 121-326 mmHg, age- and sex-adjusted < 0.001) than first wave patients. Hospital mortality was lower (19% vs. 36%, < 0.001), but not for subjects over 75 years old (46 vs. 49%). Age, number of chronic illnesses, PCT levels, CT visual score [Odds Ratio (OR) 1.022, 95% confidence interval (CI) 1.009-1.036, < 0.001] and PaO/FiO (OR 0.991, 95% CI 0.988-0.994, < 0.001), but not the pandemic wave, were associated with mortality on stepwise multivariate logistic regression analysis.
Despite the higher virulence of B.1.1.7 lineage, we detected milder clinical presentation and improved mortality in patients hospitalized during the third COVID-19 wave, with involvement of younger subjects. The reasons of this discrepancy are unclear, but could involve the population effect of vaccination campaigns, that were being conducted primarily in older frail subjects during the third wave.
新型冠状病毒肺炎(COVID-19)在不同疫情波次中临床表现存在差异的原因尚未完全明确,可能包括个体风险状况、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系以及病毒传播的季节性变化。本回顾性研究的目的是比较意大利一家大型教学医院内科病房在第一波疫情(2020年3月)和第三波疫情(2021年3月,SARS-CoV-2 B.1.1.7谱系占主导)同一季节确诊为新型冠状病毒肺炎(COVID-19)的患者的特征及结局。
从临床记录中收集了769例未接种疫苗患者的数据(第一波399例,第三波370例),包括症状类型及持续时间、胸部计算机断层扫描(CT)显示的肺部异常范围以及入院时动脉血气分析的氧合指数(PaO/FiO)。
第三波疫情患者平均年龄更小(中位数65岁,四分位间距[IQR] 55 - 75岁,第一波为72岁,IQR 61 - 81岁,P < 0.001),合并症更少,肺部受累情况(CT视觉评分中位数25,IQR 15 - 40,第一波为30,IQR 15 - 50,年龄和性别校正后P = 0.017)及呼吸受累情况(PaO/FiO中位数288,IQR 237 - 338,第一波为233,IQR 121 - 326 mmHg,年龄和性别校正后P < 0.001)均优于第一波患者。医院死亡率更低(19% 对36%,P < 0.001),但75岁以上患者死亡率无差异(46% 对49%)。在逐步多因素逻辑回归分析中,年龄、慢性病数量、降钙素原(PCT)水平、CT视觉评分[比值比(OR)1.022,95%置信区间(CI)1.009 - 1.036,P < 0.001]和PaO/FiO(OR 0.991,95% CI 0.988 - 0.994,P < 0.001)与死亡率相关,而疫情波次与死亡率无关。
尽管B.1.1.7谱系毒力更强,但我们发现第三波COVID-19疫情期间住院患者的临床表现更轻,死亡率有所改善,且涉及更年轻的人群。这种差异的原因尚不清楚,但可能与疫苗接种运动的人群效应有关,第三波疫情期间主要在老年体弱人群中开展疫苗接种。